Kala Pharmaceuticals, Inc. (0JQ2)
Market Open
15 Oct, 02:52 PM
LSE 
$
0. 20
-0.06
-22.0008%
$
- Market Cap
- P/E Ratio
- Div Yield
5,007 Volume
-18.03 Eps
$ 0.25
Previous Close Want to track 0JQ2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kala Pharmaceuticals, Inc. (0JQ2) Statistics
Valuation metrics
Market Cap -
Enterprise value 5.45M
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 196.35K
Average volume (90 days) 35.16K
Price summary
52-Week low 0.19
52-Week high 95.25
Beta -
50-Day moving average 0.55
200-Day moving average 1.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 20 Jan 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.95%
Return on equity -2.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -135.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 97.48
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 6.88%
Book value per share (mrq) 121.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
